Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» FDA
FDA
Roche wins FDA OK for targeted drug in early lung cancer
BioPharma Dive
Fri, 04/19/24 - 11:40 am
Roche
Alecensa
ALK inhibitors
FDA
non-small cell lung cancer
FDA mandates label updates on CAR-T cancer therapies
Reuters
Thu, 04/18/24 - 10:34 pm
CAR-T
FDA
warning
cancer
Gilead Sciences
Bristol Myers Squibb
2seventybio
Roche’s Early Alzheimer’s Blood Test Gets FDA Breakthrough Device Designation
Xtalks
Thu, 04/18/24 - 10:28 pm
Roche
FDA
Medtech
Eli Lilly
Elecsys pTau217
Alzheimer's disease
diagnostics
FDA fast-tracks AskBio’s heart failure gene therapy
Pharmaphorum
Thu, 04/18/24 - 11:14 am
FDA
Bayer
AskBio
heart failure
gene therapy
fast track
AB-1002
Vertex inches closer to acute pain market with FDA application acceptance
Fierce Biotech
Thu, 04/18/24 - 11:10 am
Vertex Pharmaceuticals
VX-548
acute pain
painkillers
FDA
non-opioid pain treatments
Lilly Alzheimer's med glides out of Leqembi's slipstream with FDA adcomm request
Fierce Biotech
Wed, 04/17/24 - 09:58 pm
Eli Lilly
donanemab
Alzheimer's disease
Leqembi
Biogen
Eisai
FDA
Removing the Misconceptions Surrounding Biosimilar Interchangeability
Center for Biosimilars
Tue, 04/16/24 - 07:41 am
FDA
interchangeability
biosimilars
GSK trails after Pfizer in 5-in-1 meningococcal vaccine race
Pharmaphorum
Tue, 04/16/24 - 07:35 am
GSK
meningococcal disease
Pfizer
vaccines
FDA
Bexero
Menveo
FDA establishes CDER Center for Clinical Trial Innovation
FDA
Mon, 04/15/24 - 09:33 pm
FDA
CDER
clinical trials
clinical trial innovation
Novartis touts surrogate endpoint win, nabs priority review for Fabhalta in IgAN
Fierce Pharma
Mon, 04/15/24 - 09:32 pm
Novartis
Fabhalta
IgAN
priority review
FDA
Neumora's schizophrenia drug faces FDA hold over convulsions in rabbits
Fierce Biotech
Mon, 04/15/24 - 11:00 am
Neumora Therapeutics
schizophrenia
FDA
clinical trials
NMRA-266
Candel wins FDA orphan drug designation for pancreatic cancer drug
Clinical Trials Arena
Sun, 04/14/24 - 01:23 pm
FDA
Candel Therapeutics
CAN-2409
pancreatic cancer
orphan drugs
AstraZeneca Expands Fasenra’s Label to Younger Children with Severe Asthma
BioSpace
Fri, 04/12/24 - 11:15 am
AstraZeneca
Fasenra
severe asthma
FDA
eosinophilic asthma
pediatric
FDA commissioner tells lawmakers his agency needs more authority to prevent drug shortages
Fierce Pharma
Fri, 04/12/24 - 11:12 am
FDA
Robert Califf
drug shortages
FDA puts breakthrough tag on Roche, Lilly Alzheimer’s test
Pharmaphorum
Thu, 04/11/24 - 10:52 am
diagnostics
Roche
Eli Lilly
Alzheimer's disease
FDA
breakthrough designation
AACR: Study Suggests Accelerated Approval Doesn’t Always Lead to Clinical Benefit
BioSpace
Wed, 04/10/24 - 05:44 pm
AACR
oncology
FDA
accelerated approvals
FDA gives nod to BrainStorm for ALS trial after Phase III flop
Clinical Trials Arena
Tue, 04/9/24 - 11:39 am
BrainStorm Cell Therapeutics
clinical trials
NurOwn
FDA
ALS
As FDA weighs another myeloma endpoint for accelerated approvals, experts say timely access is at stake
Fierce Pharma
Tue, 04/9/24 - 11:36 am
FDA
Multiple Myeloma
Ten doctors on FDA panel reviewing Abbott heart device had financial ties with company
Medical Marketing and Media
Mon, 04/8/24 - 05:48 pm
Medtech
Abbott Labs
FDA
TriClip G4
FDA grants breakthrough status to Dizal’s sunvozertinib
Pharmaceutical Business Review
Mon, 04/8/24 - 11:54 am
Dizal Pharmaceutical
FDA
non-small cell lung cancer
sunvozertinib
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »